Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,395,189
-$371,364 QoQ
Shares Held
99,468
+1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#880
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southeast Asset Advisors, LLC holds $26,273,942 across 7 Drug Manufacturers - General names. PFE ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,781 | $11,627,000 | |
| 2 | ABBV |
AbbVie Inc.
|
21,450 | $5,397,678 | |
| 3 | LLY |
ELI LILLY & Co
|
2,848 | $3,415,976 | |
| 4 | PFE |
Pfizer Inc
This page
|
99,468 | $2,395,189 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,706 | $1,632,721 | |
| 6 | NVS |
Novartis AG
|
6,716 | $1,052,531 | |
| 7 | AMGN |
Amgen Inc
|
2,079 | $752,847 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,395,189 | 99,468 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,766,553 | 98,524 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,331,212 | 93,623 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,933,932 | 75,900 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,201,043 | 49,548 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,283,597 | 50,655 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,187,111 | 44,746 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,353,842 | 46,781 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,326,000 | 47,391 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,298,977 | 46,810 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,461,409 | 50,761 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,728,687 | 52,116 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,785,619 | 48,681 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,982,880 | 48,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,609,960 | 50,936 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,281,077 | 52,127 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,907,558 | 55,456 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,882,035 | 55,670 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,283,652 | 55,608 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,369,807 | 55,099 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,009,221 | 51,308 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,387,319 | 38,292 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,362,485 | 37,014 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,355,770 | 36,942 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,209,247 | 36,980 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,149,252 | 35,210 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||